Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.82
0.00 (0.06%)
At close: Aug 18, 2025, 10:40 AM

Lexaria Bioscience Cash Flow Statement

Financials in USD. Fiscal year is September - August.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020
Net Income
-3.79M -2.72M -2.71M -2.19M -1.78M -649.54K -1.19M -1.25M -2.38M -1.31M -1.77M -1.51M -2.42M -1.45M -2M -1.32M -2.57M 415.19K -710.12K
Depreciation & Amortization
30.95K 2.28K 33.2K -7.76K 15.07K 15.93K 28.78K 70.93K 25.01K 24.73K 24.73K 63.33K 23.89K 26.16K 27.93K 63.81K 27.93K 27.93K 27.93K
Stock-Based Compensation
470.14K 167.22K 99.42K 96.51K 341.77K -107.91K 53.95K 9.63K 81.45K 10.53K 68.78K 232.87K 111.17K 300K 408.54K 85K 343.97K 17.15K 48.89K
Other Working Capital
549.98K -1.29M 738.29K 127.92K -145.79K -134.38K 273.5K 71.75K -327.64K -75.37K 316.42K -419.45K 64.65K 15.26K 76.81K -118.13K -22.26K -151.53K 57.04K
Other Non-Cash Items
-294.44K 881.44K 16.12K 37.85K 82.44K -87.75K 1.99K 10.95K 12.96K 22.14K 88.58K 505.12K 853.39K 252.11K 10.95K 159.19K 9.05K 8.89K 8.73K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 53.22K 250.68K -1.86K n/a n/a n/a n/a n/a 340.31K n/a 855.75K -1.46M -10.46K
Change in Working Capital
n/a 168.14K -168.14K 174.13K 76.32K -387 -134.55K -714.85K 480.04K 24.96K 353.11K -464.78K 170.75K -106.87K 49.43K 22.44K 162.16K 62.19K -183.26K
Operating Cash Flow
-3.58M -1.5M -2.73M -1.89M -1.27M -619.61K -1.18M -1.62M -1.79M -1.23M -1.23M -1.18M -1.26M -1.28M -1.17M -1.08M -1.17M -924.46K -818.3K
Capital Expenditures
n/a n/a n/a -69.59K -22K -56.99K -40.03K -68.44K -33.65K -32.68K -34.84K -50.04K -37.96K -34.42K -58.22K n/a -70.73K -2.99K -5.78K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2 n/a 273.38K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-19.44K -27.89K -37.8K -26.57K n/a -56.99K -40.03K -68.44K -33.65K -19.44K -14.34K -4 -37.96K -34.42K -15.84K -2 -70.73K 273.38K -5.78K
Investing Cash Flow
-19.44K -27.89K -37.8K -69.59K -22K -56.99K -40.03K -68.44K -33.65K -32.68K -34.84K -50.05K -37.96K -34.42K -58.22K -2 -70.73K 270.38K -5.78K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.2K n/a n/a -11.2K -11.2K n/a 419.00 -10.99K -23.16K -8.77K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.69M n/a n/a n/a 5.04M 491.82K 571.65K n/a n/a -11.2K -11.2K -11.21K n/a n/a -10.99K 3.97M n/a -13.21K n/a
Financial Cash Flow
1.69M 11.72K 4.35M n/a 5.04M 3.45M 1.82M -121.69K 1.71M n/a -11.2K -11.21K -11.2K -11.2K -10.99K 3.97M -10.99K 9.45M -8.77K
Net Cash Flow
-1.88M -1.61M 1.58M -1.96M 3.75M 2.75M 602.06K -1.81M -108.2K -1.26M -1.28M -1.24M -1.31M -1.32M -1.24M 2.81M -1.24M 8.82M -768.41K
Free Cash Flow
-3.58M -1.5M -2.73M -1.96M -1.29M -676.6K -1.22M -1.69M -1.82M -1.26M -1.27M -1.23M -1.3M -1.31M -1.22M -1.08M -1.24M -927.45K -824.08K